Cme (CME) Revenue (2009 - 2026)

Cme (CME) has reported Revenue for 18 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.

• Quarterly Revenue rose 0.84% year-over-year to $1.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.8 billion (up 5.1% YoY) and the FY2025 annual result came in at $6.5 billion, up 6.37% from the prior year.
• Revenue eased to $1.7 billion in Q2 2026 per CME's latest filing, from $1.9 billion in the prior quarter.
• Over the last five years, Revenue for CME reached as high as $1.9 billion in Q1 2026 and fell as low as $1.2 billion in Q4 2022.
• A 5-year average of $1.5 billion and a median of $1.5 billion in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2023 — Revenue climbed 19.17% — and 2025, when it slipped 2.95%.
• Year by year, Revenue stood at $1.2 billion in 2022, then advanced by 19.17% to $1.4 billion in 2023, then climbed by 5.98% to $1.5 billion in 2024, then increased by 8.09% to $1.6 billion in 2025, then grew by 3.49% to $1.7 billion in 2026.
• According to Business Quant data, Revenue over the past three periods registered $1.7 billion, $1.9 billion, and $1.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.